Literature DB >> 21237476

Influenza virus assembly and budding.

Jeremy S Rossman1, Robert A Lamb.   

Abstract

Influenza A virus causes seasonal epidemics, sporadic pandemics and is a significant global health burden. Influenza virus is an enveloped virus that contains a segmented negative strand RNA genome. Assembly and budding of progeny influenza virions is a complex, multi-step process that occurs in lipid raft domains on the apical membrane of infected cells. The viral proteins hemagglutinin (HA) and neuraminidase (NA) are targeted to lipid rafts, causing the coalescence and enlargement of the raft domains. This clustering of HA and NA may cause a deformation of the membrane and the initiation of the virus budding event. M1 is then thought to bind to the cytoplasmic tails of HA and NA where it can then polymerize and form the interior structure of the emerging virion. M1, bound to the cytoplasmic tails of HA and NA, additionally serves as a docking site for the recruitment of the viral RNPs and may mediate the recruitment of M2 to the site of virus budding. M2 initially stabilizes the site of budding, possibly enabling the polymerization of the matrix protein and the formation of filamentous virions. Subsequently, M2 is able to alter membrane curvature at the neck of the budding virus, causing membrane scission and the release of the progeny virion. This review investigates the latest research on influenza virus budding in an attempt to provide a step-by-step analysis of the assembly and budding processes for influenza viruses.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21237476      PMCID: PMC3086653          DOI: 10.1016/j.virol.2010.12.003

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  111 in total

Review 1.  Unpacking the incoming influenza virus.

Authors:  A Helenius
Journal:  Cell       Date:  1992-05-15       Impact factor: 41.582

2.  Influenza virus. Amantadine blocks the channel.

Authors:  J J Skehel
Journal:  Nature       Date:  1992-07-09       Impact factor: 49.962

3.  Expression of the influenza A virus M2 protein is restricted to apical surfaces of polarized epithelial cells.

Authors:  P G Hughey; R W Compans; S L Zebedee; R A Lamb
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

4.  Influenza virus M2 integral membrane protein is a homotetramer stabilized by formation of disulfide bonds.

Authors:  L J Holsinger; R A Lamb
Journal:  Virology       Date:  1991-07       Impact factor: 3.616

5.  Mechanisms for the modulation of membrane bilayer properties by amphipathic helical peptides.

Authors:  R M Epand; Y Shai; J P Segrest; G M Anantharamaiah
Journal:  Biopolymers       Date:  1995       Impact factor: 2.505

6.  A small percentage of influenza virus M1 protein contains zinc but zinc does not influence in vitro M1-RNA interaction.

Authors:  C Elster; E Fourest; F Baudin; K Larsen; S Cusack; R W Ruigrok
Journal:  J Gen Virol       Date:  1994-01       Impact factor: 3.891

7.  Regulated M1 mRNA splicing in influenza virus-infected cells.

Authors:  J Valcárcel; A Portela; J Ortín
Journal:  J Gen Virol       Date:  1991-06       Impact factor: 3.891

8.  Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface.

Authors:  D A Brown; J K Rose
Journal:  Cell       Date:  1992-02-07       Impact factor: 41.582

9.  Influenza virus M2 protein has ion channel activity.

Authors:  L H Pinto; L J Holsinger; R A Lamb
Journal:  Cell       Date:  1992-05-01       Impact factor: 41.582

10.  Structural characteristics of the M2 protein of influenza A viruses: evidence that it forms a tetrameric channel.

Authors:  R J Sugrue; A J Hay
Journal:  Virology       Date:  1991-02       Impact factor: 3.616

View more
  276 in total

1.  Virion architecture unifies globally distributed pleolipoviruses infecting halophilic archaea.

Authors:  Maija K Pietilä; Nina S Atanasova; Violeta Manole; Lassi Liljeroos; Sarah J Butcher; Hanna M Oksanen; Dennis H Bamford
Journal:  J Virol       Date:  2012-02-22       Impact factor: 5.103

Review 2.  Microvesicles and viral infection.

Authors:  David G Meckes; Nancy Raab-Traub
Journal:  J Virol       Date:  2011-10-05       Impact factor: 5.103

Review 3.  Helical membrane protein conformations and their environment.

Authors:  Timothy A Cross; Dylan T Murray; Anthony Watts
Journal:  Eur Biophys J       Date:  2013-09-01       Impact factor: 1.733

4.  Conformational analysis of the full-length M2 protein of the influenza A virus using solid-state NMR.

Authors:  Shu Yu Liao; Keith J Fritzsching; Mei Hong
Journal:  Protein Sci       Date:  2013-10-07       Impact factor: 6.725

5.  Low-Fidelity Assembly of Influenza A Virus Promotes Escape from Host Cells.

Authors:  Michael D Vahey; Daniel A Fletcher
Journal:  Cell       Date:  2018-11-29       Impact factor: 41.582

6.  The Influenza M2 Ectodomain Regulates the Conformational Equilibria of the Transmembrane Proton Channel: Insights from Solid-State Nuclear Magnetic Resonance.

Authors:  Byungsu Kwon; Mei Hong
Journal:  Biochemistry       Date:  2016-09-12       Impact factor: 3.162

Review 7.  Viral membrane scission.

Authors:  Jeremy S Rossman; Robert A Lamb
Journal:  Annu Rev Cell Dev Biol       Date:  2013-05-31       Impact factor: 13.827

8.  In vitro and in vivo replication of influenza A H1N1 WSN33 viruses with different M1 proteins.

Authors:  Zhiguang Ran; Ying Chen; Huigang Shen; Xiaoxiao Xiang; Qinfang Liu; Bhupinder Bawa; Wenbao Qi; Laihua Zhu; Alan Young; Juergen Richt; Wenjun Ma; Feng Li
Journal:  J Gen Virol       Date:  2012-12-19       Impact factor: 3.891

9.  Dissecting the role of COPI complexes in influenza virus infection.

Authors:  Eileen Sun; Jiang He; Xiaowei Zhuang
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

Review 10.  Molecular mechanisms driving respiratory syncytial virus assembly.

Authors:  Fyza Y Shaikh; James E Crowe
Journal:  Future Microbiol       Date:  2013-01       Impact factor: 3.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.